Skip to main content

Full Schedule

Full Schedule

  • Wednesday, August 24, 2022
  • 8:55 AM – 10:45 AM
    Session I: EGFR

    Session Moderator: Corey J. Langer, MD, FACP – Abramson Cancer Center, Hospital of the University of Pennsylvania

    Presenter: Daniel H. Sterman, MD – NYU Grossman School of Medicine

    Presenter: Helen J. Ross, MD – Banner MD Anderson Cancer Center

    Presenter: Lyudmila Bazhenova, MD – University of California, San Diego

    Presenter: Joel W. Neal, MD, PhD – Stanford University Medical Center

    Presenter: Jamie E. Chaft, MD – Memorial Sloan Kettering Cancer Center

  • 10:45 AM – 10:55 AM
    Break
  • 10:55 AM – 11:55 AM
    Non-CME Innovation Theater
  • 11:55 AM – 12:05 PM
    Break
  • 12:05 PM – 1:20 PM
    Session II: Rearrangements: ROS1 and ALK

    Session Moderator: Corey J. Langer, MD, FACP – Abramson Cancer Center, Hospital of the University of Pennsylvania

    Presenter: Sai-Hong Ignatius Ou, MD, PhD – University of California Irvine School of Medicine

    Presenter: Jessica J. Lin, MD – Harvard Medical School

  • 1:20 PM – 1:30 PM
    Break
  • 1:30 PM – 2:40 PM
    Session III: Other Actionable Biomarkers

    Session Moderator: Corey J. Langer, MD, FACP – Abramson Cancer Center, Hospital of the University of Pennsylvania

    Presenter: Karen Reckamp, MD – Cedars Sinai Medical Center

    Presenter: Benjamin Levy, MD – Johns Hopkins

    Presenter: Helen J. Ross, MD – Banner MD Anderson Cancer Center

  • Thursday, August 25, 2022
  • 9:00 AM – 10:15 AM
    Session IV: KRAS/BRAF and Other Emerging Markers

    Session Moderator: Corey J. Langer, MD, FACP – Abramson Cancer Center, Hospital of the University of Pennsylvania

    Presenter: Charu Aggarwal, MD, MPH – Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania

    Presenter: Rebecca Heist, MD, MPH – Harvard Medical School, Massachusetts General Hospital

    Presenter: Helen J. Ross, MD – Banner MD Anderson Cancer Center

  • 10:15 AM – 10:25 AM
    Break
  • 10:25 AM – 11:25 AM
    Non-CME Innovation Theater
  • 11:25 AM – 11:35 AM
    Break
  • 11:35 AM – 12:30 PM
    Session V: SCLC Basics and Controversies

    Session Moderator: Corey J. Langer, MD, FACP – Abramson Cancer Center, Hospital of the University of Pennsylvania

    Presenter: Stephen V. Liu, MD – Georgetown University

    Presenter: Kristin Higgins, MD – Winship Cancer Institute of Emory University, Dept of Radiation Oncology

  • 12:30 PM – 12:40 PM
    Break
  • 12:40 PM – 1:25 PM
    Session VI: Unique Innovations in the Realm of Immunotherapy

    Presenter: Corey J. Langer, MD, FACP – Abramson Cancer Center, Hospital of the University of Pennsylvania

    Presenter: Stephen V. Liu, MD – Georgetown University

    Presenter: Helen J. Ross, MD – Banner MD Anderson Cancer Center

  • 1:25 PM – 1:35 PM
    Break
  • 1:35 PM – 3:30 PM
    Session VII: Immune Checkpoint Inhibitors for NSCLC

    Session Moderator: Corey J. Langer, MD, FACP – Abramson Cancer Center, Hospital of the University of Pennsylvania

    Presenter: Edward B. Garon, MD, MS – University of California, Los Angeles

    Presenter: Marina Garassino, MD – University of Chicago

    Presenter: Jamie E. Chaft, MD – Memorial Sloan Kettering Cancer Center

    Presenter: Joel W. Neal, MD, PhD – Stanford University Medical Center

    Presenter: Aaron Lisberg, MD – University of California, Los Angeles

  • 3:30 PM – 3:40 PM
    Break
  • 3:40 PM – 4:55 PM
    Session VIII: Practical Considerations of ICIs for NSCLC

    Session Moderator: Corey J. Langer, MD, FACP – Abramson Cancer Center, Hospital of the University of Pennsylvania

    Presenter: Karen Reckamp, MD – Cedars Sinai Medical Center

    Presenter: Helen J. Ross, MD – Banner MD Anderson Cancer Center

    Presenter: Lyudmila Bazhenova, MD – University of California, San Diego

  • Friday, August 26, 2022
  • 8:55 AM – 10:50 AM
    Session IX: Introducing CPIs to the Curative Setting and Other Malignancies

    Presenter: Corey J. Langer, MD, FACP – Abramson Cancer Center, Hospital of the University of Pennsylvania

    Presenter: Jamie E. Chaft, MD – Memorial Sloan Kettering Cancer Center

    Presenter: Kristin Higgins, MD – Winship Cancer Institute of Emory University, Dept of Radiation Oncology

    Presenter: Joy Feliciano, MD – Hopkins Medicine

  • 10:50 AM – 11:00 AM
    Break
  • 11:00 AM – 12:00 PM
    Non-CME Innovation Theater
  • 12:00 PM – 12:10 PM
    Break
  • 12:10 PM – 1:50 PM
    Session X: Coping with COVID: Now and in the Future

    Session Moderator: Corey J. Langer, MD, FACP – Abramson Cancer Center, Hospital of the University of Pennsylvania

    Presenter: Andrew Haas, MD, PhD – University of Pennsylvania Health System

    Presenter: Sharyn Katz, MD, MTR – University of Pennsylvania Perelman School of Medicine

    Presenter: Marina Garassino, MD – University of Chicago

    Presenter: Edward B. Garon, MD, MS – University of California, Los Angeles

  • Friday, October 14, 2022
  • 8:00 AM – 9:40 AM
    Session I: EGFR

    Moderator: Corey J. Langer, MD, FACP – Abramson Cancer Center, Hospital of the University of Pennsylvania

    Presenter: Helen J. Ross, MD – Banner MD Anderson Cancer Center

    Presenter: Alexander Spira, MD, PhD, FACP – Virginia Cancer Specialists, NEXT Oncology Virginia, US Oncology Research

    Presenter: Helena Yu, MD – Memorial Sloan Kettering Cancer Center

  • 9:40 AM – 10:40 AM
    Exploring a Treatment Option for Patients with Previously Treated Metastatic Small Cell Lung Cancer (SCLC) - Amit Patel, MD
  • 9:40 AM – 10:40 AM
    Non-CME Innovation Theater (Sponsored by AstraZeneca)
  • 10:40 AM – 11:45 AM
    Session II: Rearrangements: ROS1 and ALK

    Moderator: Corey J. Langer, MD, FACP – Abramson Cancer Center, Hospital of the University of Pennsylvania

    Presenter: Sai-Hong Ignatius Ou, MD, PhD – University of California Irvine School of Medicine

    Presenter: Rajwanth Veluswamy, MD, MSCR – Icahn School of Medicine at Mount Sinai

  • 11:45 AM – 12:10 PM
    Exhibit Hall
  • 12:10 PM – 1:05 PM
    Session III: Other Actionable Biomarkers

    Moderator: Corey J. Langer, MD, FACP – Abramson Cancer Center, Hospital of the University of Pennsylvania

    Presenter: Benjamin Levy, MD – Johns Hopkins

    Presenter: Lyudmila Bazhenova, MD – University of California, San Diego

  • 1:05 PM – 2:05 PM
    EXKIVITY® (mobocertinib) The first and only oral therapy designed to target EGFR Exon20 insertion+ mNSCLC - Mohammad Jahanzeb, MD
  • 2:05 PM – 3:15 PM
    Session IV: Technologic Innovations in Thoracic Oncology
  • 2:05 PM – 3:15 PM
    Session IV: Technologic Innovations in Thoracic Oncology
  • 3:15 PM – 3:35 PM
    Exhibit Hall
  • 3:35 PM – 5:10 PM
    Session V: Introducing CPIs to the Curative Setting and Other Malignancies

    Moderator: Edward B. Garon, MD, MS – University of California, Los Angeles

    Presenter: Nasser Altorki, MD – Weill Cornell Medicine | New York Presbyterian

    Presenter: Marina Garassino, MD – University of Chicago

    Presenter: Corey J. Langer, MD, FACP – Abramson Cancer Center, Hospital of the University of Pennsylvania

  • Saturday, October 15, 2022
  • 8:20 AM – 9:55 AM
    Session VI: Immune Checkpoint Inhibitors for NSCLC

    Moderator: Edward B. Garon, MD, MS – University of California, Los Angeles

    Presenter: Marina Garassino, MD – University of Chicago

    Presenter: Leena Gandhi, MD, PhD – Harvard Medical School/Dana-Farber Cancer Institute

  • 9:55 AM – 10:55 AM
    Non-CME Innovation Theater (Sponsored by AstraZeneca)
  • 9:55 AM – 10:55 AM
    Non-CME Innovation Theater (Sponsored by Regeneron)
  • 10:55 AM – 11:10 AM
    Exhibit Hall
  • 11:10 AM – 12:30 PM
    Session VII: Practical Considerations of ICIs for NSCLC

    Moderator: Edward B. Garon, MD, MS – University of California, Los Angeles

    Presenter: Mark Awad, MD, PhD (he/him/his) – Dana-Farber Cancer Institute, Harvard Medical School

    Presenter: Lyudmila Bazhenova, MD – University of California, San Diego

    Presenter: Helen J. Ross, MD – Banner MD Anderson Cancer Center

  • 12:30 PM – 1:30 PM
    ALUNBRIG® (brigatinib) for the First-Line Treatment of ALK+ mNSCLC - Clinical Case Study: Cindy -Miguel Albino, MD
  • 1:30 PM – 2:45 PM
    Session VIII: KRAS/BRAF and Other Emerging Markers

    Moderator: Edward B. Garon, MD, MS – University of California, Los Angeles

    Presenter: Lyudmila Bazhenova, MD – University of California, San Diego

  • 2:45 PM – 3:05 PM
    Exhibit Hall
  • 3:05 PM – 4:10 PM
    Session IX: SCLC Basics and Controversies

    Moderator: Edward B. Garon, MD, MS – University of California, Los Angeles

    Presenter: Kristin Higgins, MD – Winship Cancer Institute of Emory University, Dept of Radiation Oncology

    Presenter: Ticiana Leal, MD – Emory University

  • Wednesday, November 9, 2022
  • 9:00 AM – 10:45 AM
    Session I: EGFR

    Moderator: Corey J. Langer, MD, FACP – Abramson Cancer Center, Hospital of the University of Pennsylvania

    Presenter: Lyudmila Bazhenova, MD – University of California, San Diego

    Presenter: Jamie E. Chaft, MD – Memorial Sloan Kettering Cancer Center

    Presenter: Jonathan Goldman, MD – UCLA

    Presenter: Joel W. Neal, MD, PhD – Stanford University Medical Center

  • 10:45 AM – 10:55 AM
    Exhibit Hall
  • 10:55 AM – 11:55 AM
    EXKIVITY® (mobocertinib) The first and only oral therapy designed to target EGFR Exon20 insertion+ mNSCLC
  • 11:55 AM – 12:05 PM
    Exhibit Hall
  • 12:05 PM – 1:15 PM
    Session II: Rearrangements: ROS1 and ALK

    Moderator: Edward B. Garon, MD, MS – University of California, Los Angeles

    Presenter: Jessica J. Lin, MD – Harvard Medical School

    Presenter: Rajwanth Veluswamy, MD, MSCR – Icahn School of Medicine at Mount Sinai

  • 1:15 PM – 1:35 PM
    Exhibit Hall
  • 1:35 PM – 1:40 PM
    Session III: Other Actionable Biomarkers
  • 1:35 PM – 2:35 PM
    Session III: Other Actionable Biomarkers
  • 1:35 PM – 2:50 PM
    Session III: Other Actionable Biomarkers

    Moderator: Corey J. Langer, MD, FACP – Abramson Cancer Center, Hospital of the University of Pennsylvania

    Presenter: Lyudmila Bazhenova, MD – University of California, San Diego

    Presenter: Jonathan Goldman, MD – UCLA

  • Thursday, November 10, 2022
  • 9:00 AM – 10:00 AM
    Session IV: SCLC Basics and Controversies

    Moderator: Corey J. Langer, MD, FACP – Abramson Cancer Center, Hospital of the University of Pennsylvania

    Presenter: Kristin Higgins, MD – Winship Cancer Institute of Emory University, Dept of Radiation Oncology

    Presenter: Ticiana Leal, MD – Emory University

  • 10:00 AM – 10:10 AM
    Exhibit Hall
  • 10:10 AM – 11:10 AM
    ALUNBRIG® (brigatinib) for the First-Line Treatment of ALK+ mNSCLC - Clinical Case Study: Cindy
  • 11:10 AM – 11:20 AM
    Exhibit Hall
  • 11:20 AM – 12:30 PM
    Session V: Technologic Innovations in Thoracic Oncology

    Moderator: Edward B. Garon, MD, MS – University of California, Los Angeles

    Presenter: Kristin Higgins, MD – Winship Cancer Institute of Emory University, Dept of Radiation Oncology

    Presenter: Ticiana Leal, MD – Emory University

  • 12:30 PM – 12:40 PM
    Exhibit Hall
  • 12:40 PM – 2:10 PM
    Session VI: (High)lights from Recent European Meetings

    Moderator: Corey J. Langer, MD, FACP – Abramson Cancer Center, Hospital of the University of Pennsylvania

    Presenter: Marina Garassino, MD – University of Chicago

    Presenter: Joshua K. Sabari, MD – NYU Langone Health Perlmutter Cancer Center

    Presenter: Rajwanth Veluswamy, MD, MSCR – Icahn School of Medicine at Mount Sinai

  • 2:10 PM – 2:20 PM
    Exhibit Hall
  • 2:20 PM – 2:25 PM
    Session VII: BRAF and Other Emerging Markers
  • 2:20 PM – 3:20 PM
    Session VII: BRAF and Other Emerging Markers

    Moderator: Edward B. Garon, MD, MS – University of California, Los Angeles

    Presenter: Lyudmila Bazhenova, MD – University of California, San Diego

    Presenter: Aaron Lisberg, MD – University of California, Los Angeles

  • 2:25 PM – 2:40 PM
    Session VII: BRAF and Other Emerging Markers
  • 2:40 PM – 2:55 PM
    Session VII: BRAF and Other Emerging Markers
  • 2:55 PM – 3:20 PM
    Session VII: BRAF and Other Emerging Markers
  • Friday, November 11, 2022
  • 9:00 AM – 11:00 AM
    Session VIII: Introducing CPIs to the Curative Setting and Other Malignancies

    Moderator: Edward B. Garon, MD, MS – University of California, Los Angeles

    Presenter: Jamie E. Chaft, MD – Memorial Sloan Kettering Cancer Center

    Presenter: Marina Garassino, MD – University of Chicago

    Presenter: Corey J. Langer, MD, FACP – Abramson Cancer Center, Hospital of the University of Pennsylvania

    Presenter: Joel W. Neal, MD, PhD – Stanford University Medical Center

  • 11:00 AM – 11:10 AM
    Exhibit Hall
  • 11:10 AM – 12:10 PM
    Non-CME Innvoation Theater
  • 12:10 PM – 12:20 PM
    Exhibit Hall
  • 12:20 PM – 2:10 PM
    Session IX: Immune Checkpoint Inhibitors for NSCLC

    Moderator: Corey J. Langer, MD, FACP – Abramson Cancer Center, Hospital of the University of Pennsylvania

    Presenter: Leena Gandhi, MD, PhD – Harvard Medical School/Dana-Farber Cancer Institute

    Presenter: Marina Garassino, MD – University of Chicago

    Presenter: Edward B. Garon, MD, MS – University of California, Los Angeles

    Presenter: Aaron Lisberg, MD – University of California, Los Angeles

  • 2:10 PM – 2:20 PM
    Exhibit Hall
  • 2:20 PM – 3:40 PM
    Session X: Practical Considerations of ICIs for NSCLC

    Moderator: Edward B. Garon, MD, MS – University of California, Los Angeles

    Presenter: Lyudmila Bazhenova, MD – University of California, San Diego

    Presenter: Karen Reckamp, MD – Cedars Sinai Medical Center

    Presenter: Helen J. Ross, MD – Banner MD Anderson Cancer Center